Skip to content
Application 207426
- Type
- ANDA
- Sponsor
- SAGENT PHARMS INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | SODIUM NITROPRUSSIDE | SODIUM NITROPRUSSIDE | INJECTABLE;INJECTION | 25MG/ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 25021-310 | Sodium Nitroprusside | Sodium Nitroprusside | Sagent Pharmaceuticals | ANDA | Current |
| 25021-310 | Sodium Nitroprusside | Sodium Nitroprusside | Sagent Pharmaceuticals | ANDA | Current |
| 25021-310 | Sodium Nitroprusside | Sodium Nitroprusside | Sagent Pharmaceuticals | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 47111 | ORIG | 2017-02-06 |
| 46129 | ORIG | 2016-12-13 |